1. Home
  2. WKC vs IOVA Comparison

WKC vs IOVA Comparison

Compare WKC & IOVA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo World Kinect Corporation

WKC

World Kinect Corporation

N/A

Current Price

$35.40

Market Cap

1.8B

Sector

Energy

ML Signal

N/A

Logo Iovance Biotherapeutics Inc.

IOVA

Iovance Biotherapeutics Inc.

N/A

Current Price

$8.79

Market Cap

1.7B

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
WKC
IOVA
Founded
1984
2007
Country
United States
United States
Employees
N/A
N/A
Industry
Oil Refining/Marketing
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Energy
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.8B
1.7B
IPO Year
1994
2008

Fundamental Metrics

Financial Performance
Metric
WKC
IOVA
Price
$35.40
$8.79
Analyst Decision
Hold
Buy
Analyst Count
3
10
Target Price
$28.00
$9.00
AVG Volume (30 Days)
838.5K
17.8M
Earning Date
04-23-2026
05-07-2026
Dividend Yield
2.96%
N/A
EPS Growth
N/A
14.84
EPS
1.44
N/A
Revenue
$36,916,600,000.00
N/A
Revenue This Year
$0.62
$47.74
Revenue Next Year
$3.42
$40.31
P/E Ratio
$24.33
N/A
Revenue Growth
N/A
N/A
52 Week Low
$22.21
$1.76
52 Week High
$41.20
$9.36

Technical Indicators

Market Signals
Indicator
WKC
IOVA
Relative Strength Index (RSI) 40.50 68.70
Support Level $22.77 $3.57
Resistance Level $37.88 $9.36
Average True Range (ATR) 0.87 0.58
MACD -0.18 -0.01
Stochastic Oscillator 10.53 74.12

Price Performance

Historical Comparison
WKC
IOVA

About WKC World Kinect Corporation

World Kinect Corp is an energy management company involved in providing supply fulfillment, energy procurement advisory services, and transaction and payment management solutions to commercial and industrial customers. It sells and delivers liquid fuels, natural gas, electricity, renewable energy, and other sustainability solutions. The company operates in three reportable segments consisting of aviation, land, and marine. It earns the majority of its revenue from the Aviation segment.

About IOVA Iovance Biotherapeutics Inc.

Iovance Biotherapeutics Inc is a clinical-stage biopharmaceutical company, pioneering a transformational approach to treating cancer by harnessing the human immune system's ability to recognize and destroy diverse cancer cells using therapies personalized for each patient. The company is preparing for potential U.S. regulatory approvals and commercialization of the first autologous T-cell therapy to address a solid tumor cancer. It operates in one segment, focusing on innovating, developing, and commercializing therapies using its autologous TIL cell therapies for patients with solid tumor cancers. Geographically, the company operates in United States and Rest of the World.

Share on Social Networks: